Comments on 'Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA'.

Michael Williams; Clare Shute; Sarah Wright

doi:10.1038/eye.2017.178

Comments on 'Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA'.

Michael Williams, Clare Shute, Sarah Wright

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article

172 Downloads (Pure)

Original language	English
Journal	Eye
Early online date	25 Aug 2017
DOIs	https://doi.org/10.1038/eye.2017.178
Publication status	Early online date - 25 Aug 2017

Access to Document

10.1038/eye.2017.178Licence: Unspecified

Comments on 'Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA'.
© 2017 The Royal College of Ophthalmologists. This work is made available online in accordance with the publisher’s policies. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 48.8 KBLicence: Unspecified

Cite this

Williams, M., Shute, C., & Wright, S. (2017). Comments on 'Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA'. Eye. https://doi.org/10.1038/eye.2017.178

@article{ed8b8eaa21484005b1949f4017d5314b,

title = "Comments on 'Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA'.",

author = "Michael Williams and Clare Shute and Sarah Wright",

year = "2017",

month = aug,

day = "25",

doi = "10.1038/eye.2017.178",

language = "English",

journal = "Eye",

issn = "0950-222X",

publisher = "Nature Publishing Group",

}